Cancer Noticias Destacadas Dec. 15, 2022 Colorectal cancer screening tailored to each patient's needs With the advent of less invasive colorectal cancer screening options, more care teams are tailoring screening to each patient's needs. The best screening is the one with which a patient will follow through. Nov. 03, 2022 Hepatic artery infusion pump chemotherapy spares livers and saves lives Mayo Clinic in Minnesota has begun treating liver metastases using hepatic artery infusion pump chemotherapy. This intensified, targeted chemotherapy provides potentially curative options for patients where they did not exist before. Nov. 30, 2022 Kidney-sparing therapy for low-grade upper tract urothelial cancer In a multicenter phase 3 study, researchers identified a kidney-sparing therapy for patients with a rare urologic cancer. Mayo Clinic experts enhanced the mitomycin-containing reverse thermal gel for safety and fewer adverse events. Oct. 20, 2022 Cancer vaccines illuminate more personalized treatment and prevention strategies Researchers at Mayo Clinic are studying the use of vaccines to treat and prevent cancer. With vaccines in various stages of clinical and preclinical research, personalized treatment options using vaccines are on the horizon. GI Neoplasia Clinic There are many new and established ways to test and treat patients with gastrointestinal neoplasia at Mayo Clinic. Liver cancer innovations and advanced treatment options Liver cancer specialists at Mayo Clinic Comprehensive Cancer Center offer hope to patients in the form of the highest quality therapies available. At the Cancer Center, patients with liver cancer may have access to personalized chemotherapy regimens, proton beam and other highly focused radiation therapies and prostate-specific membrane antigen. Quality liver cancer screening provides the most favorable treatment options Sumera I. Ilyas, M.B.B.S., a gastroenterologist at Mayo Clinic Comprehensive Cancer Center, explains that potentially curative liver cancer treatments are available only for early-stage disease. Quality liver cancer screening and knowledge of when screening and further testing should occur are imperative. Calculators These models are to be used by medical professionals. Publications E-NEWSLETTER EDITION See the latest edition plus past issues 1 Clonal hematopoiesis clinic stratifies risk for patients with cancer 2 Weekly dose of erlotinib shows decreased duodenal polyp burden and side effects for patients with FAP 3 Support patients' return to sexual health following cancer treatment 4 Improved overall survival for Hodgkin lymphoma with brentuximab vedotin 5 De-escalated therapy improves quality of life following oropharynx cancer treatment Profesionales médicos Cancer